GL1X · GenesisL1 explorer

MolNFT v1 · #73863 · protein

Crystal structure of wild-type INHA:NADH complex

3OEW · Enoyl-[acyl-carrier-protein] reductase [NADH]: “Crystal structure of wild-type INHA:NADH complex”. X-ray diffraction, 1 ligand (NAD), 2 pockets (best druggability 0.79). MolNFT v1 #73863 on GenesisL1: 3D structure, binding sites and…

PDB
3OEW
Type
protein
Length
267 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
P0A5Y6
Ligands
NAD
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26748% helix, 16% strandP0A5Y6

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16820.790.8351NAD, MPD
2770.370.7716empty

Compared structures

  • 3OEW · Crystal structure of wild-type InhA:NADH complex · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.